{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-027337","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.149465+00:00","generated_at":"2026-05-26T03:51:33.981172+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vera Therapeutics reports 2024 net loss $152.1M; atacicept Phase 3 primary endpoint due Q2 2025","bullets":["Net loss of $152.1M ($2.75 diluted EPS) vs $96.0M ($2.25) in 2023; cash burn $134.7M operating.","Cash and equivalents $640.9M as of Dec 31, 2024; sufficient through potential 2026 commercial launch.","Phase 3 ORIGIN trial primary endpoint expected Q2 2025; BLA submission for atacicept planned H2 2025.","Expanded pipeline: atacicept in PMN, FSGS, MCD; acquired next-gen fusion protein VT-109 in 2024.","FDA Breakthrough Therapy Designation granted for atacicept in IgAN during 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-027337","json":"https://secwatch.observer/filing/0000950170-25-027337.json","markdown":"https://secwatch.observer/filing/0000950170-25-027337.md","text":"https://secwatch.observer/filing/0000950170-25-027337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000095017025027337/0000950170-25-027337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000095017025027337/vera-20250226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:51:33.981172+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001493152-26-026777","ticker":"IVF","company_name":"INVO Fertility, Inc.","filed_at":"2026-06-02T12:40:33+00:00","headline":"INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026777","json":"https://secwatch.observer/filing/0001493152-26-026777.json","markdown":"https://secwatch.observer/filing/0001493152-26-026777.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315226026777/0001493152-26-026777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315226026777/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026770","ticker":"POLA","company_name":"Polar Power, Inc.","filed_at":"2026-06-02T12:30:26+00:00","headline":"Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026770","json":"https://secwatch.observer/filing/0001493152-26-026770.json","markdown":"https://secwatch.observer/filing/0001493152-26-026770.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622345/000149315226026770/0001493152-26-026770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622345/000149315226026770/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-069202","ticker":"CTRN","company_name":"Citi Trends Inc","filed_at":"2026-06-02T10:58:00+00:00","headline":"Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069202","json":"https://secwatch.observer/filing/0001104659-26-069202.json","markdown":"https://secwatch.observer/filing/0001104659-26-069202.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1318484/000110465926069202/0001104659-26-069202-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1318484/000110465926069202/tm2616574d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039379","ticker":null,"company_name":"DAVEY TREE EXPERT CO","filed_at":"2026-06-01T17:50:11+00:00","headline":"Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039379","json":"https://secwatch.observer/filing/0001628280-26-039379.json","markdown":"https://secwatch.observer/filing/0001628280-26-039379.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/277638/000162828026039379/0001628280-26-039379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/277638/000162828026039379/davey-20260528.htm"},"side_by_side_evidence":null},{"accession":"0000885245-26-000025","ticker":"BKE","company_name":"BUCKLE INC","filed_at":"2026-05-29T19:38:39+00:00","headline":"Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000885245-26-000025","json":"https://secwatch.observer/filing/0000885245-26-000025.json","markdown":"https://secwatch.observer/filing/0000885245-26-000025.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/885245/000088524526000025/0000885245-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885245/000088524526000025/bke-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062458","ticker":"HIND","company_name":"Vyome Holdings, Inc","filed_at":"2026-05-29T12:42:42+00:00","headline":"Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062458","json":"https://secwatch.observer/filing/0001213900-26-062458.json","markdown":"https://secwatch.observer/filing/0001213900-26-062458.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/0001213900-26-062458-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/ea0292643-8k_vyome.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-018758","ticker":"PKE","company_name":"PARK AEROSPACE CORP","filed_at":"2026-05-28T20:29:07+00:00","headline":"Park Aerospace Q4 sales up 43% to $24.2M; EPS $0.19 vs $0.06 YoY; full-year net earnings double to $11.3M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018758","json":"https://secwatch.observer/filing/0001437749-26-018758.json","markdown":"https://secwatch.observer/filing/0001437749-26-018758.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/76267/000143774926018758/0001437749-26-018758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/76267/000143774926018758/pke20260528_8k.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-038825","ticker":"GAP","company_name":"GAP INC","filed_at":"2026-05-28T20:16:53+00:00","headline":"Gap Inc. Q1 net sales up 1% to $3.5B; adj. EPS $0.38; raises full-year EPS outlook","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-038825","json":"https://secwatch.observer/filing/0001628280-26-038825.json","markdown":"https://secwatch.observer/filing/0001628280-26-038825.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/39911/000162828026038825/0001628280-26-038825-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/39911/000162828026038825/gps-20260528.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}